Award
NIH Reporter #11379002
Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer
Recipient
National Cancer Institute (NCI)
Award Amount
$641,673.00
Ceiling
$641,673.00
Awarded
September 15, 2026
Identifier
11379002
This award funds a randomized trial to test a telehealth behavioral intervention (EASE) designed to reduce fear of progression and trauma symptoms in adults with advanced cancer, aiming to improve quality of life and mental health outcomes.
Description
A randomized trial of a behavioral intervention called EASE, based on written exposure therapy, aimed at reducing fear of progression and cancer-related trauma symptoms among adults with advanced cancer. The trial compares EASE delivered via telehealth with usual care in a 2-arm study with 250 participants. The intervention is offered in English and Spanish and aims to improve quality of life, reduce anxiety, depression, and hopelessness, and inform evidence-based care guidelines.